Compounds > 1,25-dihydroxyergocalciferol
Page last updated: 2024-09-03

1,25-dihydroxyergocalciferol and Secondary Hyperparathyroidism

1,25-dihydroxyergocalciferol has been researched along with Secondary Hyperparathyroidism in 1 studies

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19901 (100.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Kawaguchi, Y; Miyahara, T; Momose, M; Morita, T; Nakayama, M; Ogawa, A; Shigematsu, T; Suzuki, M; Unemura, S; Yamamoto, H1

Other Studies

1 other study(ies) available for 1,25-dihydroxyergocalciferol and Secondary Hyperparathyroidism

ArticleYear
[A trial of suppressing secondary hyperparathyroidism by oral high dose therapy of 1, 25-dihydroxyvitamin D3].
    Nihon Jinzo Gakkai shi, 1989, Volume: 31, Issue:4

    Topics: Administration, Oral; Aged; Calcitriol; Ergocalciferols; Humans; Hyperparathyroidism, Secondary; Kidney Failure, Chronic; Male; Middle Aged; Parathyroid Hormone; Renal Dialysis

1989